Oral anticoagulation across diabetic subtypes in patients with newly diagnosed atrial fibrillation: A report from the GARFIELD-AF registry.

Diabetes, obesity & metabolism(2023)

引用 0|浏览20
暂无评分
摘要
In both patients with DM and patients without DM with AF, OAC was associated with lower risk of all-cause mortality and stroke/SE. Patients with insulin-requiring DM derived significant benefit from OAC.
更多
查看译文
关键词
atrial fibrillation, cardiovascular disease, cohort study, observational study, oral anticoagulants, type 2 diabetes
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要